Guangjun X. Nie
Beijing Key Laboratory For Drug Delivery Nanocarriers
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 299 publications
Reprogrammed apoptotic platelets drive rapid hemostasis through phosphatidylserine and prostaglandin E2 signaling in preclinical models.
Journal: Science translational medicine
Published: May 21, 2026
Zwitterionic Lipid Nanotherapeutics from Mulberry for Oral Treatment of Diabetic Colitis.
Journal: ACS nano
Published: May 11, 2026
Synthetic biology integrated with material science paves the way for next-generation smart cell therapies.
Journal: Molecular therapy. Oncology
Published: March 11, 2026
Nanotechnology enabled proximity-induced protein degradation from multiscale bottlenecks to precision therapeutics.
Journal: Advanced drug delivery reviews
Published: February 18, 2026
A biomimetic Nano-platelet as an antidote for dual antiplatelet therapy-induced bleeding.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 09, 2026
Predominant mutated non-canonical tumor-specific antigens identified by proteogenomics demonstrate immunogenicity and tumor suppression in CRC.
Journal: Cell genomics
Published: January 23, 2026
The association between neutrophil-to-lymphocyte ratio and Parkinson disease, integrating data from global burden of disease study and NHANES databases.
Journal: Medicine
Published: January 22, 2026
Design Principles of Oral Nanomedicines to Overcome the Delivery Barriers.
Journal: ACS nano
Published: January 15, 2026
On-demand cancer immunotherapy via single-cell encapsulation of synthetic circuit-engineered cells.
Journal: Science advances
Published: January 14, 2026
Last Updated: 09/26/2026